{"entity":{"type":"insider","cik":"0001573722","url":"/insider/0001573722","json_url":"/insider/0001573722.json","name":"Hoberman Kenneth","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":30,"first":"2013-11-27","last":"2022-05-16","span_basis":"filed_date"},"name_variants":[{"name":"Hoberman Kenneth","source":"filing","n_filings":30,"first_seen":"2013-11-27","last_seen":"2022-05-16"}],"transactions":[{"id":6476050,"accession":"0001104659-22-060913","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-060913","line_url":"/filing/0001104659-22-060913#line-1","is_derivative":false,"issuer_cik":"0001573722","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001573722","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":17.4,"price_display":"17.40","price_state":"stated","total_value":104400.0,"total_display":"104,400.00","shares_owned_after":55140.0,"shares_owned_after_display":"55,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-16","scope":"insider"},{"id":3328397,"accession":"0001104659-20-033491","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-033491","line_url":"/filing/0001104659-20-033491#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16704.0,"shares_display":"16,704","price_per_share":4.91,"price_display":"4.91","price_state":"stated","total_value":82016.64,"total_display":"82,016.64","shares_owned_after":771764.0,"shares_owned_after_display":"771,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-13","scope":"insider"},{"id":3328394,"accession":"0001104659-20-033491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-033491","line_url":"/filing/0001104659-20-033491#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9487.0,"shares_display":"9,487","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":48193.96,"total_display":"48,193.96","shares_owned_after":788468.0,"shares_owned_after_display":"788,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-13","scope":"insider"},{"id":2339319,"accession":"0001104659-20-027397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-027397","line_url":"/filing/0001104659-20-027397#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11547.0,"shares_display":"11,547","price_per_share":6.42,"price_display":"6.42","price_state":"stated","total_value":74131.74,"total_display":"74,131.74","shares_owned_after":797955.0,"shares_owned_after_display":"797,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-25","filed_date":"2020-02-28","scope":"insider"},{"id":2516658,"accession":"0001104659-20-006882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-006882","line_url":"/filing/0001104659-20-006882#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22139.0,"shares_display":"22,139","price_per_share":7.02,"price_display":"7.02","price_state":"stated","total_value":155415.78,"total_display":"155,415.78","shares_owned_after":601085.0,"shares_owned_after_display":"601,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-22","filed_date":"2020-01-24","scope":"insider"},{"id":2048560,"accession":"0001104659-20-003149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-003149","line_url":"/filing/0001104659-20-003149#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13228.0,"shares_display":"13,228","price_per_share":10.37,"price_display":"10.37","price_state":"stated","total_value":137174.36,"total_display":"137,174.36","shares_owned_after":623224.0,"shares_owned_after_display":"623,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-01-10","scope":"insider"},{"id":2048556,"accession":"0001104659-20-000980","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-20-000980","line_url":"/filing/0001104659-20-000980#line-4","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2022.0,"shares_display":"2,022","price_per_share":10.48,"price_display":"10.48","price_state":"stated","total_value":21190.56,"total_display":"21,190.56","shares_owned_after":636452.0,"shares_owned_after_display":"636,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-27","filed_date":"2020-01-03","scope":"insider"},{"id":2048554,"accession":"0001104659-20-000980","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-000980","line_url":"/filing/0001104659-20-000980#line-3","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15494.0,"shares_display":"15,494","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":166560.5,"total_display":"166,560.50","shares_owned_after":638474.0,"shares_owned_after_display":"638,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-26","filed_date":"2020-01-03","scope":"insider"},{"id":2048552,"accession":"0001104659-20-000980","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-000980","line_url":"/filing/0001104659-20-000980#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24477.0,"shares_display":"24,477","price_per_share":10.97,"price_display":"10.97","price_state":"stated","total_value":268512.69,"total_display":"268,512.69","shares_owned_after":653968.0,"shares_owned_after_display":"653,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-24","filed_date":"2020-01-03","scope":"insider"},{"id":2048549,"accession":"0001104659-20-000980","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-000980","line_url":"/filing/0001104659-20-000980#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4319.0,"shares_display":"4,319","price_per_share":10.58,"price_display":"10.58","price_state":"stated","total_value":45695.02,"total_display":"45,695.02","shares_owned_after":678445.0,"shares_owned_after_display":"678,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-23","filed_date":"2020-01-03","scope":"insider"},{"id":8145958,"accession":"0001104659-19-038310","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-038310","line_url":"/filing/0001104659-19-038310#line-3","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12508.0,"shares_display":"12,508","price_per_share":14.77,"price_display":"14.77","price_state":"stated","total_value":184743.16,"total_display":"184,743.16","shares_owned_after":682764.0,"shares_owned_after_display":"682,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-26","filed_date":"2019-06-28","scope":"insider"},{"id":8145954,"accession":"0001104659-19-038310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-038310","line_url":"/filing/0001104659-19-038310#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25500.0,"shares_display":"25,500","price_per_share":15.07,"price_display":"15.07","price_state":"stated","total_value":384285.0,"total_display":"384,285.00","shares_owned_after":695272.0,"shares_owned_after_display":"695,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-25","filed_date":"2019-06-28","scope":"insider"},{"id":8145950,"accession":"0001104659-19-038310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-038310","line_url":"/filing/0001104659-19-038310#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9107.0,"shares_display":"9,107","price_per_share":15.49,"price_display":"15.49","price_state":"stated","total_value":141067.43,"total_display":"141,067.43","shares_owned_after":720772.0,"shares_owned_after_display":"720,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-24","filed_date":"2019-06-28","scope":"insider"},{"id":8026501,"accession":"0001104659-19-030357","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-030357","line_url":"/filing/0001104659-19-030357#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25817.0,"shares_display":"25,817","price_per_share":14.27,"price_display":"14.27","price_state":"stated","total_value":368408.59,"total_display":"368,408.59","shares_owned_after":729879.0,"shares_owned_after_display":"729,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-17","scope":"insider"},{"id":7889074,"accession":"0001104659-19-015344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-015344","line_url":"/filing/0001104659-19-015344#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":981.0,"shares_display":"981","price_per_share":11.04,"price_display":"11.04","price_state":"stated","total_value":10830.24,"total_display":"10,830.24","shares_owned_after":755696.0,"shares_owned_after_display":"755,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-15","scope":"insider"},{"id":7889072,"accession":"0001104659-19-015344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-015344","line_url":"/filing/0001104659-19-015344#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25101.0,"shares_display":"25,101","price_per_share":11.11,"price_display":"11.11","price_state":"stated","total_value":278872.11,"total_display":"278,872.11","shares_owned_after":756677.0,"shares_owned_after_display":"756,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-11","filed_date":"2019-03-15","scope":"insider"},{"id":8547867,"accession":"0001104659-19-013684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-013684","line_url":"/filing/0001104659-19-013684#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2995.0,"shares_display":"2,995","price_per_share":11.36,"price_display":"11.36","price_state":"stated","total_value":34023.2,"total_display":"34,023.20","shares_owned_after":781778.0,"shares_owned_after_display":"781,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-07","filed_date":"2019-03-08","scope":"insider"},{"id":8053590,"accession":"0001104659-19-011257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-011257","line_url":"/filing/0001104659-19-011257#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10557.0,"shares_display":"10,557","price_per_share":12.05,"price_display":"12.05","price_state":"stated","total_value":127211.85,"total_display":"127,211.85","shares_owned_after":784773.0,"shares_owned_after_display":"784,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider"},{"id":8115880,"accession":"0001104659-19-001650","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-001650","line_url":"/filing/0001104659-19-001650#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13547.0,"shares_display":"13,547","price_per_share":10.15,"price_display":"10.15","price_state":"stated","total_value":137502.05,"total_display":"137,502.05","shares_owned_after":646652.0,"shares_owned_after_display":"646,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-08","filed_date":"2019-01-11","scope":"insider"},{"id":6333259,"accession":"0001104659-18-070899","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-070899","line_url":"/filing/0001104659-18-070899#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26296.0,"shares_display":"26,296","price_per_share":11.85,"price_display":"11.85","price_state":"stated","total_value":311607.6,"total_display":"311,607.60","shares_owned_after":659738.0,"shares_owned_after_display":"659,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-26","filed_date":"2018-11-30","scope":"insider"},{"id":6517026,"accession":"0001104659-18-017586","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-18-017586","line_url":"/filing/0001104659-18-017586#line-3","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12746.0,"shares_display":"12,746","price_per_share":16.82,"price_display":"16.82","price_state":"stated","total_value":214387.72,"total_display":"214,387.72","shares_owned_after":409594.0,"shares_owned_after_display":"409,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-14","scope":"insider"},{"id":6517023,"accession":"0001104659-18-017586","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-017586","line_url":"/filing/0001104659-18-017586#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13942.0,"shares_display":"13,942","price_per_share":17.18,"price_display":"17.18","price_state":"stated","total_value":239523.56,"total_display":"239,523.56","shares_owned_after":425639.0,"shares_owned_after_display":"425,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider"},{"id":6517019,"accession":"0001104659-18-017586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-017586","line_url":"/filing/0001104659-18-017586#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3299.0,"shares_display":"3,299","price_per_share":18.24,"price_display":"18.24","price_state":"stated","total_value":60173.76,"total_display":"60,173.76","shares_owned_after":422340.0,"shares_owned_after_display":"422,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider"},{"id":6220946,"accession":"0001104659-18-016434","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-016434","line_url":"/filing/0001104659-18-016434#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3027.0,"shares_display":"3,027","price_per_share":16.55,"price_display":"16.55","price_state":"stated","total_value":50096.85,"total_display":"50,096.85","shares_owned_after":369278.0,"shares_owned_after_display":"369,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-07","filed_date":"2018-03-09","scope":"insider"},{"id":5958347,"accession":"0001104659-18-013695","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-013695","line_url":"/filing/0001104659-18-013695#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5726.0,"shares_display":"5,726","price_per_share":17.26,"price_display":"17.26","price_state":"stated","total_value":98830.76,"total_display":"98,830.76","shares_owned_after":371915.0,"shares_owned_after_display":"371,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-27","filed_date":"2018-02-28","scope":"insider"},{"id":5958344,"accession":"0001104659-18-013695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-013695","line_url":"/filing/0001104659-18-013695#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":17.61,"price_display":"17.61","price_state":"stated","total_value":93333.0,"total_display":"93,333.00","shares_owned_after":377641.0,"shares_owned_after_display":"377,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-26","filed_date":"2018-02-28","scope":"insider"},{"id":6288676,"accession":"0001104659-18-010450","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-010450","line_url":"/filing/0001104659-18-010450#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1851.0,"shares_display":"1,851","price_per_share":15.67,"price_display":"15.67","price_state":"stated","total_value":29005.17,"total_display":"29,005.17","shares_owned_after":382941.0,"shares_owned_after_display":"382,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-16","scope":"insider"},{"id":6621721,"accession":"0001104659-18-002137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-002137","line_url":"/filing/0001104659-18-002137#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14040.0,"shares_display":"14,040","price_per_share":13.93,"price_display":"13.93","price_state":"stated","total_value":195577.2,"total_display":"195,577.20","shares_owned_after":384792.0,"shares_owned_after_display":"384,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-08","filed_date":"2018-01-12","scope":"insider"},{"id":4074477,"accession":"0001104659-17-074139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-074139","line_url":"/filing/0001104659-17-074139#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40.0,"shares_display":"40","price_per_share":14.75,"price_display":"14.75","price_state":"stated","total_value":590.0,"total_display":"590.00","shares_owned_after":398832.0,"shares_owned_after_display":"398,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-18","filed_date":"2017-12-19","scope":"insider"},{"id":4074475,"accession":"0001104659-17-074139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-074139","line_url":"/filing/0001104659-17-074139#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11943.0,"shares_display":"11,943","price_per_share":14.18,"price_display":"14.18","price_state":"stated","total_value":169351.74,"total_display":"169,351.74","shares_owned_after":398872.0,"shares_owned_after_display":"398,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-15","filed_date":"2017-12-19","scope":"insider"},{"id":5055415,"accession":"0001104659-17-015592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-015592","line_url":"/filing/0001104659-17-015592#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2342.0,"shares_display":"2,342","price_per_share":8.16,"price_display":"8.16","price_state":"stated","total_value":19110.72,"total_display":"19,110.72","shares_owned_after":277674.0,"shares_owned_after_display":"277,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-09","scope":"insider"},{"id":4527738,"accession":"0001104659-17-013194","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-013194","line_url":"/filing/0001104659-17-013194#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4027.0,"shares_display":"4,027","price_per_share":7.01,"price_display":"7.01","price_state":"stated","total_value":28229.27,"total_display":"28,229.27","shares_owned_after":279655.0,"shares_owned_after_display":"279,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-01","scope":"insider"},{"id":4527735,"accession":"0001104659-17-013194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-013194","line_url":"/filing/0001104659-17-013194#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":6.97,"price_display":"6.97","price_state":"stated","total_value":27880.0,"total_display":"27,880.00","shares_owned_after":283682.0,"shares_owned_after_display":"283,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-27","filed_date":"2017-03-01","scope":"insider"},{"id":4485471,"accession":"0001104659-17-010293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-010293","line_url":"/filing/0001104659-17-010293#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1508.0,"shares_display":"1,508","price_per_share":6.42,"price_display":"6.42","price_state":"stated","total_value":9681.36,"total_display":"9,681.36","shares_owned_after":287682.0,"shares_owned_after_display":"287,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-17","scope":"insider"},{"id":4977722,"accession":"0001104659-17-002351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-002351","line_url":"/filing/0001104659-17-002351#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9110.0,"shares_display":"9,110","price_per_share":13.82,"price_display":"13.82","price_state":"stated","total_value":125900.2,"total_display":"125,900.20","shares_owned_after":289190.0,"shares_owned_after_display":"289,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-10","filed_date":"2017-01-13","scope":"insider"},{"id":2868563,"accession":"0001104659-16-104300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-104300","line_url":"/filing/0001104659-16-104300#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2412.0,"shares_display":"2,412","price_per_share":5.34,"price_display":"5.34","price_state":"stated","total_value":12880.08,"total_display":"12,880.08","shares_owned_after":297392.0,"shares_owned_after_display":"297,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-08","filed_date":"2016-03-10","scope":"insider"},{"id":2823719,"accession":"0001104659-16-098576","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-098576","line_url":"/filing/0001104659-16-098576#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1503.0,"shares_display":"1,503","price_per_share":4.54,"price_display":"4.54","price_state":"stated","total_value":6823.62,"total_display":"6,823.62","shares_owned_after":211059.0,"shares_owned_after_display":"211,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-19","scope":"insider"},{"id":8319136,"accession":"0001104659-15-021403","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-021403","line_url":"/filing/0001104659-15-021403#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17307.0,"shares_display":"17,307","price_per_share":16.43,"price_display":"16.43","price_state":"stated","total_value":284354.01,"total_display":"284,354.01","shares_owned_after":122119.0,"shares_owned_after_display":"122,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-20","scope":"insider"},{"id":8857682,"accession":"0001104659-15-012683","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-012683","line_url":"/filing/0001104659-15-012683#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1593.0,"shares_display":"1,593","price_per_share":14.02,"price_display":"14.02","price_state":"stated","total_value":22333.86,"total_display":"22,333.86","shares_owned_after":87942.0,"shares_owned_after_display":"87,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-18","filed_date":"2015-02-20","scope":"insider"},{"id":6277006,"accession":"0001104659-14-064491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-064491","line_url":"/filing/0001104659-14-064491#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":10.9877,"price_display":"10.99","price_state":"stated","total_value":21975.4,"total_display":"21,975.40","shares_owned_after":89535.0,"shares_owned_after_display":"89,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-03","scope":"insider"},{"id":6307802,"accession":"0001104659-14-041435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-041435","line_url":"/filing/0001104659-14-041435#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15250.0,"shares_display":"15,250","price_per_share":13.32,"price_display":"13.32","price_state":"stated","total_value":203130.0,"total_display":"203,130.00","shares_owned_after":87535.0,"shares_owned_after_display":"87,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-21","filed_date":"2014-05-23","scope":"insider"},{"id":4487000,"accession":"0001104659-13-087577","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-13-087577","line_url":"/filing/0001104659-13-087577#line-8","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15411.0,"shares_display":"15,411","price_per_share":19.91,"price_display":"19.91","price_state":"stated","total_value":306833.01,"total_display":"306,833.01","shares_owned_after":87800.0,"shares_owned_after_display":"87,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-27","filed_date":"2013-11-27","scope":"insider"},{"id":4486993,"accession":"0001104659-13-087577","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-13-087577","line_url":"/filing/0001104659-13-087577#line-6","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3144.0,"shares_display":"3,144","price_per_share":21.27,"price_display":"21.27","price_state":"stated","total_value":66872.88,"total_display":"66,872.88","shares_owned_after":69238.0,"shares_owned_after_display":"69,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-26","filed_date":"2013-11-27","scope":"insider"},{"id":4486985,"accession":"0001104659-13-087577","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-13-087577","line_url":"/filing/0001104659-13-087577#line-4","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14350.0,"shares_display":"14,350","price_per_share":21.94,"price_display":"21.94","price_state":"stated","total_value":314839.0,"total_display":"314,839.00","shares_owned_after":65415.0,"shares_owned_after_display":"65,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-25","filed_date":"2013-11-27","scope":"insider"},{"id":4486977,"accession":"0001104659-13-087577","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-13-087577","line_url":"/filing/0001104659-13-087577#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001573722","owner_name":"Hoberman Kenneth","owner_url":"/insider/0001573722","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11523.0,"shares_display":"11,523","price_per_share":20.14,"price_display":"20.14","price_state":"stated","total_value":232073.22,"total_display":"232,073.22","shares_owned_after":42765.0,"shares_owned_after_display":"42,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-22","filed_date":"2013-11-27","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":45,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":43,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":45},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001875558","name":"Nuvectis Pharma, Inc.","url":"/issuer/0001875558","role":"Director","n_filings":1,"first_seen":"2022-05-16","last_seen":"2022-05-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001264587","name":"STEMLINE THERAPEUTICS INC","url":"/issuer/0001264587","role":"Officer (Chief Operating Officer)","n_filings":29,"first_seen":"2013-11-27","last_seen":"2020-03-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001573722","retrieved_at":"2026-08-21T08:14:45+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}